Overview
Aceruloplasminemia is a rare inherited condition where the body cannot make a working form of a protein called ceruloplasmin. Ceruloplasmin normally helps move iron out of cells, especially in the brain, liver, and pancreas. Without it, iron builds up slowly in these organs over many years, causing serious damage. The disease is also sometimes called 'hereditary ceruloplasmin deficiency.' The iron buildup causes a combination of problems that are unusual to see together: diabetes (from damage to the pancreas), anemia (low red blood cells, from problems in the liver), and neurological symptoms (from iron damage to the brain). Brain symptoms often include movement problems like tremors or difficulty walking, as well as memory and thinking difficulties. Eye problems, including a condition called retinal degeneration, can also occur. Most people do not notice symptoms until adulthood, often in their 40s or 50s, because the iron builds up slowly over decades. There is no cure, but treatments aimed at reducing iron levels — such as iron-chelating medications — can help slow the disease. Managing diabetes and anemia is also an important part of care. Early diagnosis is key to preventing the worst outcomes.
Also known as:
Key symptoms:
Diabetes (high blood sugar)Anemia (low red blood cells causing tiredness and paleness)Involuntary shaking or tremorsDifficulty walking or coordinating movementsMemory problems or confusionSlow or slurred speechVision loss or retinal damageAbnormal eye movementsDifficulty swallowingPsychiatric symptoms such as depression or behavioral changesIron buildup visible on brain MRI scans
Clinical phenotype terms (41)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
1 eventData sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableATryn
Prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesLariam
Hoffmann-La Roche, Inc.
Lariam Patient Support (Genentech Access Solutions)
Travel Grants
No travel grants are currently matched to Aceruloplasminemia.
Community
No community posts yet. Be the first to share your experience with Aceruloplasminemia.
Start the conversation →Latest news about Aceruloplasminemia
Disease timeline:
New recruiting trial: TIRCON International NBIA Registry
A new clinical trial is recruiting patients for Aceruloplasminemia
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What stage is my iron buildup at, and which organs are most affected right now?,Should I start iron chelation therapy, and which medication would be best for me?,How often should I have MRI scans and blood tests to monitor my condition?,Are any of my family members at risk, and should they be tested?,Are there any clinical trials I might be eligible for?,What symptoms should prompt me to seek emergency care?,What specialists should be part of my care team, and how often should I see each one?
Common questions about Aceruloplasminemia
What is Aceruloplasminemia?
Aceruloplasminemia is a rare inherited condition where the body cannot make a working form of a protein called ceruloplasmin. Ceruloplasmin normally helps move iron out of cells, especially in the brain, liver, and pancreas. Without it, iron builds up slowly in these organs over many years, causing serious damage. The disease is also sometimes called 'hereditary ceruloplasmin deficiency.' The iron buildup causes a combination of problems that are unusual to see together: diabetes (from damage to the pancreas), anemia (low red blood cells, from problems in the liver), and neurological symptoms
How is Aceruloplasminemia inherited?
Aceruloplasminemia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Aceruloplasminemia typically begin?
Typical onset of Aceruloplasminemia is adult. Age of onset can vary across affected individuals.
Are there clinical trials for Aceruloplasminemia?
Yes — 1 recruiting clinical trial is currently listed for Aceruloplasminemia on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Aceruloplasminemia?
20 specialists and care centers treating Aceruloplasminemia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Aceruloplasminemia?
2 patient support programs are currently tracked on UniteRare for Aceruloplasminemia. See the treatments and support programs sections for copay assistance, eligibility, and contact details.